NCT07246863 2026-03-04
Trial Investigating Visugromab and Nivolumab With or Without Docetaxel in 2L Treatment of Participants With Metastatic NSCLC
CatalYm GmbH
Phase 2 Recruiting
Clinical Trials
6 trialsNCT05849129 2026-01-23
AIVAA
The Canadian College of Naturopathic Medicine
Phase 2 Recruiting
NCT05730816 2025-11-21
MAGIC-AKI
Brigham and Women's Hospital
Phase 2 Recruiting
NCT01411202 2020-09-25
OPUS
Ottawa Hospital Research Institute
Phase 2 Unknown
NCT00850577 2015-10-12
Ph II of a Novel Anti-angiogenic Agent in Combination With Chemotherapy for the Treatment of Non-Small Cell Lung Cancer
Bristol-Myers Squibb
Phase 2 Terminated
NCT00504725 2014-07-25
KITS
Duke University
Phase 2 Completed